ChemoCentryx
CCXI
#3654
Rank
NZ$6.80 B
Marketcap
NZ$94.63
Share price
0.00%
Change (1 day)
37.63%
Change (1 year)

Market capitalization of ChemoCentryx (CCXI.defunct)

Last known market cap: NZ$6.80 Billion

On November 25, 2022 ChemoCentryx had a market cap of NZ$6.80 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ChemoCentryx from 2012 to 2022

End of year Market Cap

Year Marketcap Change
2022NZ$5.88 B57.76%
2021NZ$3.73 B-37.15%
2020NZ$5.93 B67.9%
2019NZ$3.53 B329.36%
2018NZ$0.82 B101.65%
2017NZ$0.40 B-20%
2016NZ$0.51 B-2.34%
2015NZ$0.52 B38.08%
2014NZ$0.37 B25.33%
2013NZ$0.30 B-37.5%
2012NZ$0.48 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$1.221 T 17,843.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$295.35 B 4,239.94%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$942.07 B 13,742.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$450.83 B 6,524.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$67.47 B 891.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$643.30 B 9,352.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$228.24 B 3,253.87%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$179.64 B 2,539.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$90.51 B 1,230.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel